ALT vs VRTX: Which Stock is Better?
Side-by-side comparison of Altimmune Inc and Vertex Pharmaceuticals Inc in 2026
ALT
Altimmune Inc
$3.60
VRTX
Vertex Pharmaceuticals Inc
$492.38
Key Metrics Comparison
| Metric | ALT | VRTX | Winner |
|---|---|---|---|
| Market Cap | $475.88M | $126.79B | VRTX |
| P/E Ratio | N/A | 32.58 | VRTX |
| EPS (TTM) | $N/A | $15.32 | VRTX |
| Revenue Growth | 4.2% | 0.1% | ALT |
| Gross Margin | -161929.3% | 53.7% | VRTX |
Analyze ALT
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALT or VRTX a better investment?
Comparing ALT and VRTX: Altimmune Inc has a market cap of $475.88M while Vertex Pharmaceuticals Inc has $126.79B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALT and VRTX?
ALT (Altimmune Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALT or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALT or VRTX?
ALT has higher revenue growth at 4.2% vs 0.1% for VRTX.
Which company is more profitable: ALT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -161929.3% for ALT.
Which is the larger company: ALT or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.79B compared to $475.88M for ALT.
Should I buy ALT or VRTX in 2026?
Both ALT and VRTX have investment merit. ALT trades at $3.60 while VRTX trades at $492.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALT and VRTX stock?
Key differences: Market Cap ($475.88M vs $126.79B), P/E Ratio (N/A vs 32.6x), Revenue Growth (4.2% vs 0.1%), Gross Margin (-161929.3% vs 53.7%).